Therapy targeting antigen-specific T cells by a peptide-based tolerizing vaccine against autoimmune arthritis. 2023

Vilma Urbonaviciute, and Laura Romero-Castillo, and Bingze Xu, and Huqiao Luo, and Nadine Schneider, and Sylvia Weisse, and Nhu-Nguyen Do, and Ana Oliveira-Coelho, and Gonzalo Fernandez Lahore, and Taotao Li, and Pierre Sabatier, and Christian M Beusch, and Johan Viljanen, and Roman A Zubarev, and Jan Kihlberg, and Johan Bäcklund, and Harald Burkhardt, and Rikard Holmdahl
Division for Medical Inflammation Research, Department of Medical Biochemistry and Biophysics, Karolinska Institute 17177 Stockholm, Sweden.

A longstanding goal has been to find an antigen-specific preventive therapy, i.e., a vaccine, for autoimmune diseases. It has been difficult to find safe ways to steer the targeting of natural regulatory antigen. Here, we show that the administration of exogenous mouse major histocompatibility complex class II protein bounding a unique galactosylated collagen type II (COL2) peptide (Aq-galCOL2) directly interacts with the antigen-specific TCR through a positively charged tag. This leads to expanding a VISTA-positive nonconventional regulatory T cells, resulting in a potent dominant suppressive effect and protection against arthritis in mice. The therapeutic effect is dominant and tissue specific as the suppression can be transferred with regulatory T cells, which downregulate various autoimmune arthritis models including antibody-induced arthritis. Thus, the tolerogenic approach described here may be a promising dominant antigen-specific therapy for rheumatoid arthritis, and in principle, for autoimmune diseases in general.

UI MeSH Term Description Entries
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000906 Antibodies Immunoglobulin molecules having a specific amino acid sequence by virtue of which they interact only with the ANTIGEN (or a very similar shape) that induced their synthesis in cells of the lymphoid series (especially PLASMA CELLS).
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis
D001327 Autoimmune Diseases Disorders that are characterized by the production of antibodies that react with host tissues or immune effector cells that are autoreactive to endogenous peptides. Autoimmune Disease,Disease, Autoimmune,Diseases, Autoimmune
D050378 T-Lymphocytes, Regulatory CD4-positive T cells that inhibit immunopathology or autoimmune disease in vivo. They inhibit the immune response by influencing the activity of other cell types. Regulatory T-cells include naturally occurring CD4+CD25+ cells, IL-10 secreting Tr1 cells, and Th3 cells. Regulatory T Cell,Regulatory T-Cell,Regulatory T-Lymphocyte,Regulatory T-Lymphocytes,Suppressor T-Lymphocytes, Naturally-Occurring,T-Cells, Regulatory,Th3 Cells,Tr1 Cell,Treg Cell,Regulatory T-Cells,Suppressor T-Cells, Naturally-Occurring,Tr1 Cells,Treg Cells,Cell, Regulatory T,Cell, Th3,Cell, Tr1,Cell, Treg,Cells, Regulatory T,Cells, Th3,Cells, Tr1,Cells, Treg,Naturally-Occurring Suppressor T-Cell,Naturally-Occurring Suppressor T-Cells,Naturally-Occurring Suppressor T-Lymphocyte,Naturally-Occurring Suppressor T-Lymphocytes,Regulatory T Cells,Regulatory T Lymphocyte,Regulatory T Lymphocytes,Suppressor T Cells, Naturally Occurring,Suppressor T Lymphocytes, Naturally Occurring,Suppressor T-Cell, Naturally-Occurring,Suppressor T-Lymphocyte, Naturally-Occurring,T Cell, Regulatory,T Cells, Regulatory,T Lymphocytes, Regulatory,T-Cell, Naturally-Occurring Suppressor,T-Cells, Naturally-Occurring Suppressor,T-Lymphocyte, Regulatory,Th3 Cell
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D022223 Vaccines, Subunit Vaccines consisting of one or more antigens that stimulate a strong immune response. They are purified from microorganisms or produced by recombinant DNA techniques, or they can be chemically synthesized peptides. Subunit Vaccine,Subunit Vaccines,Vaccine, Subunit

Related Publications

Vilma Urbonaviciute, and Laura Romero-Castillo, and Bingze Xu, and Huqiao Luo, and Nadine Schneider, and Sylvia Weisse, and Nhu-Nguyen Do, and Ana Oliveira-Coelho, and Gonzalo Fernandez Lahore, and Taotao Li, and Pierre Sabatier, and Christian M Beusch, and Johan Viljanen, and Roman A Zubarev, and Jan Kihlberg, and Johan Bäcklund, and Harald Burkhardt, and Rikard Holmdahl
July 2000, Journal of neuroimmunology,
Vilma Urbonaviciute, and Laura Romero-Castillo, and Bingze Xu, and Huqiao Luo, and Nadine Schneider, and Sylvia Weisse, and Nhu-Nguyen Do, and Ana Oliveira-Coelho, and Gonzalo Fernandez Lahore, and Taotao Li, and Pierre Sabatier, and Christian M Beusch, and Johan Viljanen, and Roman A Zubarev, and Jan Kihlberg, and Johan Bäcklund, and Harald Burkhardt, and Rikard Holmdahl
June 2013, Current opinion in immunology,
Vilma Urbonaviciute, and Laura Romero-Castillo, and Bingze Xu, and Huqiao Luo, and Nadine Schneider, and Sylvia Weisse, and Nhu-Nguyen Do, and Ana Oliveira-Coelho, and Gonzalo Fernandez Lahore, and Taotao Li, and Pierre Sabatier, and Christian M Beusch, and Johan Viljanen, and Roman A Zubarev, and Jan Kihlberg, and Johan Bäcklund, and Harald Burkhardt, and Rikard Holmdahl
January 2006, Arthritis research & therapy,
Vilma Urbonaviciute, and Laura Romero-Castillo, and Bingze Xu, and Huqiao Luo, and Nadine Schneider, and Sylvia Weisse, and Nhu-Nguyen Do, and Ana Oliveira-Coelho, and Gonzalo Fernandez Lahore, and Taotao Li, and Pierre Sabatier, and Christian M Beusch, and Johan Viljanen, and Roman A Zubarev, and Jan Kihlberg, and Johan Bäcklund, and Harald Burkhardt, and Rikard Holmdahl
December 2006, Autoimmunity,
Vilma Urbonaviciute, and Laura Romero-Castillo, and Bingze Xu, and Huqiao Luo, and Nadine Schneider, and Sylvia Weisse, and Nhu-Nguyen Do, and Ana Oliveira-Coelho, and Gonzalo Fernandez Lahore, and Taotao Li, and Pierre Sabatier, and Christian M Beusch, and Johan Viljanen, and Roman A Zubarev, and Jan Kihlberg, and Johan Bäcklund, and Harald Burkhardt, and Rikard Holmdahl
September 2013, Oncoimmunology,
Vilma Urbonaviciute, and Laura Romero-Castillo, and Bingze Xu, and Huqiao Luo, and Nadine Schneider, and Sylvia Weisse, and Nhu-Nguyen Do, and Ana Oliveira-Coelho, and Gonzalo Fernandez Lahore, and Taotao Li, and Pierre Sabatier, and Christian M Beusch, and Johan Viljanen, and Roman A Zubarev, and Jan Kihlberg, and Johan Bäcklund, and Harald Burkhardt, and Rikard Holmdahl
March 2021, Molecular therapy : the journal of the American Society of Gene Therapy,
Vilma Urbonaviciute, and Laura Romero-Castillo, and Bingze Xu, and Huqiao Luo, and Nadine Schneider, and Sylvia Weisse, and Nhu-Nguyen Do, and Ana Oliveira-Coelho, and Gonzalo Fernandez Lahore, and Taotao Li, and Pierre Sabatier, and Christian M Beusch, and Johan Viljanen, and Roman A Zubarev, and Jan Kihlberg, and Johan Bäcklund, and Harald Burkhardt, and Rikard Holmdahl
January 2019, Human gene therapy,
Vilma Urbonaviciute, and Laura Romero-Castillo, and Bingze Xu, and Huqiao Luo, and Nadine Schneider, and Sylvia Weisse, and Nhu-Nguyen Do, and Ana Oliveira-Coelho, and Gonzalo Fernandez Lahore, and Taotao Li, and Pierre Sabatier, and Christian M Beusch, and Johan Viljanen, and Roman A Zubarev, and Jan Kihlberg, and Johan Bäcklund, and Harald Burkhardt, and Rikard Holmdahl
October 2022, JCI insight,
Vilma Urbonaviciute, and Laura Romero-Castillo, and Bingze Xu, and Huqiao Luo, and Nadine Schneider, and Sylvia Weisse, and Nhu-Nguyen Do, and Ana Oliveira-Coelho, and Gonzalo Fernandez Lahore, and Taotao Li, and Pierre Sabatier, and Christian M Beusch, and Johan Viljanen, and Roman A Zubarev, and Jan Kihlberg, and Johan Bäcklund, and Harald Burkhardt, and Rikard Holmdahl
July 1999, The Journal of allergy and clinical immunology,
Vilma Urbonaviciute, and Laura Romero-Castillo, and Bingze Xu, and Huqiao Luo, and Nadine Schneider, and Sylvia Weisse, and Nhu-Nguyen Do, and Ana Oliveira-Coelho, and Gonzalo Fernandez Lahore, and Taotao Li, and Pierre Sabatier, and Christian M Beusch, and Johan Viljanen, and Roman A Zubarev, and Jan Kihlberg, and Johan Bäcklund, and Harald Burkhardt, and Rikard Holmdahl
August 2003, Current rheumatology reports,
Copied contents to your clipboard!